Fibroblast Growth Factor 2 lethally sensitizes cancer cells to stress‐targeted therapeutic inhibitors

In malignant transformation, cellular stress‐response pathways are dynamically mobilized to counterbalance oncogenic activity, keeping cancer cells viable. Therapeutic disruption of this vulnerable homeostasis might change the outcome of many human cancers, particularly those for which no effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Dias, Matheus H., Fonseca, Cecília S., Zeidler, Julianna D., Albuquerque, Layra L., da Silva, Marcelo S., Cararo‐Lopes, Eduardo, Reis, Marcelo S., Noël, Vincent, dos Santos, Edmilson O., Prior, Ian A., Armelin, Hugo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360366/
https://www.ncbi.nlm.nih.gov/pubmed/30422399
http://dx.doi.org/10.1002/1878-0261.12402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360366/
https://www.ncbi.nlm.nih.gov/pubmed/30422399
http://dx.doi.org/10.1002/1878-0261.12402

Ejemplares similares